Publications by authors named "Sarah Brode"

Claim this Profile
N
Nontuberculous Mycobacterial Disease in Solid-Organ Transplant Recipients and the General Population.
Seyed M Hosseini-Moghaddam, Daniel Fridman, Samantha S M Drover, Theodore K Marras, Sarah K Brode

JAMA Netw Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
Omri A Arbiv, Thomas Holmes, Marie JeongMin Kim, Marie Yan, Kamila Romanowski, Sarah K Brode

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors.
Marie Yan, Alejandro Hernandez, Kelvin K Chan, Matthew B Stanbrook, Phillip S Blanchette, Sarah K Brode

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data.
Joseph H Puyat, Sarah K Brode, Hennady Shulha, Kamila Romanowski, Dick Menzies

Clin Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Canadian Bronchiectasis and Nontuberculous Mycobacteria Registry: a study protocol.
Christina S Thornton, Nicole Boechler, Vidhi Desai, Ranjani Somayaji, Swathi Purighalla, Sarah Brode

ERJ Open Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
Jennifer H Ku, Emily Henkle, Kathleen F Carlson, Miguel Marino, Sarah K Brode

Chest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
Marie Yan, Brooke Fraser, Eric McArthur, Matty Mehrabi, Sarah K Brode

Chest· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis.
Jonathon R Campbell, Sarah K Brode, Pennan Barry, Mayara Lisboa Bastos, Maryline Bonnet

Thorax· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease.
Marie Yan, Sarah K Brode, Theodore K Marras

Clin Chest Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Marie Yan, Jonathon R Campbell, Theodore K Marras, Sarah K Brode

CMAJ· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
Lauren C Ramsay, Marina Richardson, Rafael N Miranda, Marian Hassan, Sarah K Brode

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020.
Theodore K Marras, Paul Nelson, Adriana Peci, Melissa Richard-Greenblatt, Sarah Brode

Emerg Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection.
Marie Yan, Jonathon R Campbell, Theodore K Marras, Sarah K Brode

CMAJ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.
Brett D Edwards, Henry Mah, Natasha F Sabur, Sarah K Brode

J Assoc Med Microbiol Infect Dis Can· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
Jennifer H Ku, Emily Henkle, Kathleen F Carlson, Miguel Marino, Sarah K Brode

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
Marie Yan, Sarah K Brode, Theodore K Marras

Chest· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
Jonathon R Campbell, Placide Nsengiyumva, Leslie Y Chiang, Frances Jamieson, Hadeel Khadawardi, Sarah K Brode

Emerg Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada.
Daan Raats, Sarah K Brode, Mahtab Mehrabi, Theodore K Marras

Emerg Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Positive Culture Detection Predicts Pulmonary Disease Severity and Treatment Initiation.
Brett D Edwards, Sarah K Brode, Mahtab Mehrabi, Theodore K Marras

Ann Am Thorac Soc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on Tuberculosis Prevention and Treatment in Canada: A Multicenter Analysis of 10 833 Patients.
Coralie Geric, Mariane Saroufim, David Landsman, Jonathan Richard, Andrea Benedetti, Sarah K Brode

J Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients.
Takashi Hirama, Lianne G Singer, Sarah K Brode, Theodore K Marras, Shahid Husain

Transpl Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated with antimycobacterial treatment initiation but not response.
Daan Raats, Sharina M S Aldhaheri, Theodore K Marras, Mahtab Mehrabi, Sarah K Brode

Respir Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB).
Natasha F Sabur, Mantaj S Brar, Lisa Wu, Sarah K Brode

BMC Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012.
Lauren C Ramsay, Emily Shing, John Wang, Theodore K Marras, Jeffrey C Kwong, Sarah K Brode

Emerg Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underutilization of nontuberculous mycobacterial drug susceptibility testing in Ontario, Canada, 2010-2015.
Elizabeth R Andrews, Alex Marchand-Austin, Jennifer Ma, Kirby Cronin, Meenu Sharma, Sarah K Brode

J Assoc Med Microbiol Infect Dis Can· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis